TLS•November 17, 2026 at 10:45 AM UTCSoftware & Services

Telos Q3 Beat Sparks Rally, But Valuation Now Reflects Turnaround

Read source article

What happened

Telos reported Q3 2026 revenue and earnings above consensus, extending its streak of better-than-expected results. The stock experienced a sharp rally following the release, pushing its valuation to levels that now appear to embed significant future margin expansion. The Seeking Alpha author notes that this expansion is not yet visible in current profitability, which remains constrained by low-margin software resales. The author stays on the sidelines until the company demonstrates material profitability improvement, which is not expected until 2027 when those resales are phased out. However, the company's $58 million in recurring Xacta and services bookings provides a potential catalyst as upfront implementation costs are absorbed.

Implication

The Q3 beat confirms operational momentum, but the sharp price appreciation has likely eliminated the margin of safety that existed at lower levels. With the stock now trading above the previous trim threshold of $5.75, existing holders may consider taking profits, while new buyers should wait for a pullback toward the $3.80 attractive entry zone. The core thesis hinges on sustained positive cash flow and avoidance of dilution, but the high valuation increases downside risk if federal procurement or margins disappoint. The recurring bookings of $58 million are a positive sign, but their benefit to profitability may be delayed until 2027, and the company still faces concentration risk with ~91% of revenue from federal agencies. Until there is clearer evidence that adjusted EBITDA margins can exceed 12% on a sustained basis, the risk-reward is unfavorable at current prices.

Thesis delta

Previous deep value rating was WAIT with an attractive entry of $3.80 and trim above $5.75. The Q3 2026 beat and subsequent rally likely push the stock above the trim zone, reducing the margin of safety. The thesis does not shift fundamentally; it remains wait-and-see, but the risk/reward has deteriorated as valuation now prices in future margin expansion that may not arrive until 2027. The main new positive is the $58M recurring bookings, but that is offset by the stock's rise.

Confidence

Moderate